Varda Space Industries, the microgravity-enabled life sciences company, raises $187 million in Series C funding to make ...

Venture capital companies remained the most active space investors in recent months, contributing 77% of 2025 funding in the ...

Rocket Lab's high-margin data networks and Neutron's potential $5.6B revenue could drive growth. Click here to read an ...

Rooted in Varda’s early photography, the Musée Carnavalet’s show illuminates and clarifies the singular nature of a great ...

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.

Varda Space Industries has secured $187 million from investors, including Natural Capital and Shrug Capital, to advance its ...

Varda Space Industries has announced a successful $187 million funding round, led by Natural Capital and Shrug Capital. The ...

Varda Space Industries has raised $187 million to accelerate drug development in space using microgravity technology.

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...